Experimental and clinical studies have shown that in the adaptive stage of metabolic stress-induced cardiomyopathy, the activity of both Pgc-1α and Pparα is high, which drives the balance of energy metabolism toward greater fatty acid oxidation to generate more ATP. This evidence concerns the gene PPARGC1A and cardiomyopathy.